137 related articles for article (PubMed ID: 29459814)
1. [Porphyria cutanea tarda as extrahepatic manifestation of chronic hepatitis C: a case report].
Espinoza-Ríos J; Valenzuela Granados V; Ojeda Cisneros M; Gálvez Canseco A; Ramos Aguilar C; Raymundo Villalva B; Aguilar Sánchez V; Pinto Valdivia J; Huerta-Mercado Tenorio J; Bussalleu Rivera A
Rev Gastroenterol Peru; 2017; 37(4):394-398. PubMed ID: 29459814
[TBL] [Abstract][Full Text] [Related]
2. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C.
Jessner W; Der-Petrossian M; Christiansen L; Maier H; Steindl-Munda P; Gangl A; Ferenci P
Hepatology; 2002 Nov; 36(5):1301-2. PubMed ID: 12395349
[No Abstract] [Full Text] [Related]
3. Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels.
Furuta M; Kaito M; Gabazza E; Fujita N; Ishida S; Tamaki S; Ikeda R; Wakisawa S; Hayashi H; Watanabe S; Adachi Y
J Gastroenterol; 2000; 35(1):60-2. PubMed ID: 10632544
[TBL] [Abstract][Full Text] [Related]
4. [Development of porphyria cutanea tarda in a chronic hepatitis C patient with indetectable viremia under treatment with peg-interferon plus ribavirin].
Frider B; Buonsante ME; Tiscornia J; Alessio A; Pellerano G
Acta Gastroenterol Latinoam; 2006 Mar; 36(1):38-41. PubMed ID: 16706076
[TBL] [Abstract][Full Text] [Related]
5. Severe pruritus after completing pegylated interferon for hepatitis C.
Hoffman CJ; Ray SC
AIDS Read; 2008 Nov; 18(11):562-5. PubMed ID: 19062400
[TBL] [Abstract][Full Text] [Related]
6. Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/sofosbuvir for hepatitis C.
Takata K; Shakado S; Sakamoto K; Fukuda H; Yamauchi R; Fukuda S; Kunimoto H; Umeda K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Sakisaka S
Clin J Gastroenterol; 2017 Oct; 10(5):459-463. PubMed ID: 28884440
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of porphyria cutanea tarda during peginterferon/ribavirin therapy for chronic viral hepatitis C.
Thevenot T; Bachmeyer C; Hammi R; Dumouchel P; Ducamp-Posak I; Cadranel JF
J Hepatol; 2005 Apr; 42(4):607-8. PubMed ID: 15763350
[TBL] [Abstract][Full Text] [Related]
8. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
Quecedo L; Costa J; Enríquez de Salamanca R
Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
[TBL] [Abstract][Full Text] [Related]
9. Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy.
Berk DR; Mallory SB; Keeffe EB; Ahmed A
Clin Gastroenterol Hepatol; 2007 Feb; 5(2):142-51. PubMed ID: 16919505
[TBL] [Abstract][Full Text] [Related]
10. Porphyria Cutanea Tarda Improvement With Elbasvir/Grazoprevir in End-Stage Renal Disease.
Sehmbey G; Seetharam A
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):e121. PubMed ID: 30099101
[No Abstract] [Full Text] [Related]
11. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of extrahepatic manifestations associated with hepatitis C virus infection].
Cacoub P
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B210-9. PubMed ID: 12180291
[No Abstract] [Full Text] [Related]
13. [Extrahepatic manifestations in hepatitis C].
Risum M
Ugeskr Laeger; 2011 May; 173(19):1346-9. PubMed ID: 21561571
[TBL] [Abstract][Full Text] [Related]
14. Case for diagnosis. Sclerodermiform manifestations of porphyria cutanea tarda secondary to hepatitis C.
Calado JOA; Bastos LMH; Miot HA
An Bras Dermatol; 2019; 94(4):479-481. PubMed ID: 31644627
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of hepatitis C virus associated extrahepatic manifestations].
Duclos-Vallée JC
Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B76-81. PubMed ID: 12180311
[No Abstract] [Full Text] [Related]
16. Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.
Bruzzone B; Magnani O; Sticchi L; Canepa P; Rappazzo E; Icardi G; Setti M
J Antimicrob Chemother; 2017 Oct; 72(10):2955-2958. PubMed ID: 29091216
[No Abstract] [Full Text] [Related]
17. Treatment of chronic hepatitis with boceprevir leads to remission of porphyria cutanea tarda.
Aguilera P; Laguno M; To-Figueras J
Br J Dermatol; 2014 Dec; 171(6):1595-6. PubMed ID: 25154788
[No Abstract] [Full Text] [Related]
18. Chronic hepatitis C with extrahepatic manifestations.
Poantă L; Albu A
Rom J Intern Med; 2007; 45(1):85-8. PubMed ID: 17966447
[TBL] [Abstract][Full Text] [Related]
19. The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
Chan OT; Tsai N; Wong RL; Izumi AK
Cutis; 2006 Dec; 78(6):397-400. PubMed ID: 17243426
[TBL] [Abstract][Full Text] [Related]
20. Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C.
Sheikh MY; Wright RA; Burruss JB
Dig Dis Sci; 1998 Mar; 43(3):529-33. PubMed ID: 9539647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
